StockData
Rezolute, Inc. logo

Rezolute, Inc. (RZLT) stock

RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$4.25+0.24 (+5.85%)

Close on Nov 18, 2026Market cap $411.07MP/E –Yield –

Rezolute operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Rezolute's operating income for the twelve months ending Sep 30, 2026 was -$82.53M. For fiscal 2026 it was -$82.97M. The highest annual figure on record is -$392.98K in fiscal 2011.

Annual operating income

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$82.97M–
FY2025Jun 30, 2025-$79.89M–
FY2024Jun 30, 2024-$70.42M–
FY2023Jun 30, 2023-$55.99M–
FY2022Jun 30, 2022-$41.84M–
FY2021Jun 30, 2021-$22.89M–
FY2020Jun 30, 2020-$20.52M–
FY2019Jun 30, 2019-$25.94M–
FY2018Jun 30, 2018-$28.73M–
FY2017Jun 30, 2017-$20.32M–
FY2016Jun 30, 2016-$14.95M–
FY2015Jun 30, 2015-$10.70M–
FY2014Jun 30, 2014-$5.18M–
FY2011Dec 31, 2011-$392.98K–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026-$19.39M–
Q4 FY2026CQ2 2026Jun 30, 2026-$21.56M–
Q3 FY2026CQ1 2026Mar 31, 2026-$17.37M–
Q2 FY2026CQ4 2025Dec 31, 2025-$24.22M–
Q1 FY2026CQ3 2025Sep 30, 2025-$19.82M–
Q4 FY2025CQ2 2025Jun 30, 2025-$25.85M–
Q3 FY2025CQ1 2025Mar 31, 2025-$20.02M–
Q2 FY2025CQ4 2024Dec 31, 2024-$17.08M–
Q1 FY2025CQ3 2024Sep 30, 2024-$16.94M–
Q4 FY2024CQ2 2024Jun 30, 2024-$23.10M–
Q3 FY2024CQ1 2024Mar 31, 2024-$16.21M–
Q2 FY2024CQ4 2023Dec 31, 2023-$15.19M–
Q1 FY2024CQ3 2023Sep 30, 2023-$15.91M–
Q4 FY2023CQ2 2023Jun 30, 2023-$14.24M–
Q3 FY2023CQ1 2023Mar 31, 2023-$17.14M–
Q2 FY2023CQ4 2022Dec 31, 2022-$14.39M–
Q1 FY2023CQ3 2022Sep 30, 2022-$10.22M–
Q4 FY2022CQ2 2022Jun 30, 2022-$11.30M–
Q3 FY2022CQ1 2022Mar 31, 2022-$10.75M–
Q2 FY2022CQ4 2021Dec 31, 2021-$12.15M–
Q1 FY2022CQ3 2021Sep 30, 2021-$7.64M–
Q4 FY2021CQ2 2021Jun 30, 2021-$6.64M–
Q3 FY2021CQ1 2021Mar 31, 2021-$5.48M–
Q2 FY2021CQ4 2020Dec 31, 2020-$7.15M–
Q1 FY2021CQ3 2020Sep 30, 2020-$3.62M–
Q4 FY2020CQ2 2020Jun 30, 2020-$3.55M–
Q3 FY2020CQ1 2020Mar 31, 2020-$5.07M–
Q2 FY2020CQ4 2019Dec 31, 2019-$6.72M–
Q1 FY2020CQ3 2019Sep 30, 2019-$5.18M–
Q4 FY2018CQ2 2018Jun 30, 2018-$11.31M–
Q3 FY2018CQ1 2018Mar 31, 2018-$4.95M–
Q2 FY2018CQ4 2017Dec 31, 2017-$5.75M–
Q1 FY2018CQ3 2017Sep 30, 2017-$6.72M–
Q4 FY2017CQ2 2017Jun 30, 2017-$6.22M–
Q3 FY2017CQ1 2017Mar 31, 2017-$5.39M–
Q2 FY2017CQ4 2016Dec 31, 2016-$4.89M–
Q1 FY2017CQ3 2016Sep 30, 2016-$3.82M–
Q4 FY2016CQ2 2016Jun 30, 2016-$3.87M–
Q3 FY2016CQ1 2016Mar 31, 2016-$3.72M–

More Rezolute figures

See a number that looks wrong?